Before any protocol begins, the clinical team reviews IGF-1 levels, relevant hormone panels, and your medical history
In the context of retatrutide and alcohol, harm reduction means drinking less, spacing drinks further apart, planning safe transportation, monitoring for adverse effects, and making informed decisions rather than simply being told dont drink. Triple Receptor Agonist A medication that activates three different receptors: GLP-1, GIP, and glucagon
The most common side effects were: Nausea Vomiting Diarrhea Constipation Fatigue Abdominal discomfort Early satiety Injection site reactions Increased heart rate in the first 24 weeks, but that returned to normal after 24 weeks
- Privacy: Assess from home or anywhere
All treatment decisions are made collaboratively between the patient and a PlexusDx-affiliated healthcare provider